Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Physician Warning on Overlooked Acetaminophen Hazards

Share Article

The Firm is evaluating Tylenol lawsuits on behalf of individuals who allegedly suffered serious liver damage due to acetaminophen in Tylenol-brand medications.

Free Case Review
Dozens of Tylenol lawsuits have been filed in U.S. courts on behalf of people who allegedly suffered liver damage from Tylenol.

As Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) involving liver damage allegations continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that a prominent doctor and medical researcher has warned that acetaminophen, the active ingredient in Tylenol products, poses hazards that are often overlooked by consumers. William M. Lee, MD, an internal medicine physician at Parkland Memorial Hospital who has done extensive research on acetaminophen-induced liver failure, recently told the Celina Record that liver damage is a common injury associated with acetaminophen poisoning. Unfortunately, people often think that because some acetaminophen is effective at reducing aches and pains, more is better, according to Dr. Lee.*

“Dozens of Tylenol lawsuits have been filed in U.S. courts on behalf of people who allegedly suffered liver damage from Tylenol. Despite their near-ubiquitous presence in U.S. households and over-the-counter status, these medications are associated with some serious risks,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.

Tylenol Liver Damage Litigation
According to a recent report published by The Philadelphia Inquirer, 78,000 people require emergency room care every year due to toxic reactions to acetaminophen, the active ingredient in Tylenol products. Such injuries also result in about 33,000 hospitalizations every year.** In April, the U.S. Food & Drug Administration (FDA) announced that prescription drugs containing more than 325 milligrams of acetaminophen were no longer considered safe and were being voluntarily removed from the market.***

In August 2013, Bloomberg.com reported that over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen, well over the new limits for prescription medications set by the FDA. That same month, McNeil Consumer Healthcare announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medication.****

According to court documents, more than 140 Tylenol lawsuits have been filed in the U.S. District Court, Eastern District of Pennsylvania on behalf of individuals who allegedly suffered injuries due to acetaminophen in Tylenol products. In many cases, plaintiffs claim that liver damage occurred even though the drugs were used in accordance with label directions, and resulted in hospitalization, the need for liver transplantation or death. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

Alleged victims of Tylenol liver damage may be entitled to compensation for their injury-related damages. To learn more about the association between Tylenol and liver damage, please contact Bernstein Liebhard LLP’s website. To arrange for a free legal review, please call 800-511-5092.

*starlocalmedia.com/celinarecord/news/parkland-expert-warns-acetaminophen-hazards-often-overlooked/article_3cb31c7a-fcab-11e3-8786-001a4bcf887a.html, Celina Record, June 25, 2014
**articles.philly.com/2014-02-17/news/47382323_1_acetaminophen-poisoning-tylenol-maker-kate-trunk, Philadelphia Inquirer, February 17, 2014
***latimes.com/science/sciencenow/la-sci-sn-extra-strength-acetaminophen-fda-20140428,0,6108401.story, LA Times, April 28, 2014
****bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York States contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firms fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:

Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website